A prospective analysis of red blood cell membrane polyunsaturated fatty acid levels and risk of non-Hodgkin lymphoma
- PMID: 36255154
- PMCID: PMC9877158
- DOI: 10.1080/10428194.2022.2131419
A prospective analysis of red blood cell membrane polyunsaturated fatty acid levels and risk of non-Hodgkin lymphoma
Abstract
Published studies report inconsistent associations of polyunsaturated fatty acid (PUFA) intake with non-Hodgkin lymphoma (NHL) risk. We conducted a nested case-control study in Nurses' Health Study and Health Professionals Follow-Up Study participants to evaluate a hypothesis of inverse association of pre-diagnosis red blood cell (RBC) membrane PUFA levels with risk of NHL endpoints. We confirmed 583 NHL cases and matched 583 controls by cohort/sex, age, race and blood draw date/time. We estimated odds ratios (OR) and 95% confidence intervals (CI) for risk of NHL endpoints using logistic regression. RBC PUFA levels were not associated with all NHL risk; cis 20:2n-6 was associated with follicular lymphoma risk (OR [95% CI] per one standard deviation increase: 1.35 [1.03-1.77]), and the omega-6/omega-3 PUFA ratio was associated with diffuse large B-cell lymphoma risk (2.33 [1.23-4.43]). Overall, PUFA did not demonstrate a role in NHL etiology; the two unexpected positive associations lack clear biologic explanations.
Keywords: Red blood cell membrane fatty acids; epidemiology; etiology; non-Hodgkin lymphoma; polyunsaturated fatty acids; prospective.
Conflict of interest statement
Disclosure statement: SC is presently an employee at AbbVie, in which capacity she receives stock/stock options; SZ is presently an employee and holds restricted share units of Johnson & Johnson; neither SC nor SZ had competing interests or conflicts at the time the project was designed, funded and initiated. The remaining authors declare no potential competing interests or conflicts of interest.
References
-
- Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7–33. - PubMed
-
- Cerhan JR, Vajdic CM, Spinelli JJ. The Non-Hodgkin Lymphomas. In: Michael Thun, Linet Martha S., Cerhan James R., Haiman Christopher A., Schottenfeld D, editors. Cancer Epidemiology and Prevention. USA: Oxford University Press; 2017. p 767–796.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources